Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT00978861
Clinical Study to Evaluate of The Whitening Efficacy and Safety of REMEWHITE
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 31, 2008
Completion: Aug 31, 2009
NCT04008771
Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases
Phase: N/A
Start: Jan 6, 2014
Completion: Dec 19, 2014
NCT05841862
Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)
Start: Mar 20, 2024
Completion: Mar 31, 2025